J. C. McLaughlin

777 total citations
28 papers, 613 citations indexed

About

J. C. McLaughlin is a scholar working on Infectious Diseases, Pharmacology and Epidemiology. According to data from OpenAlex, J. C. McLaughlin has authored 28 papers receiving a total of 613 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 7 papers in Pharmacology and 6 papers in Epidemiology. Recurrent topics in J. C. McLaughlin's work include Antibiotics Pharmacokinetics and Efficacy (7 papers), Bacterial Identification and Susceptibility Testing (6 papers) and Escherichia coli research studies (6 papers). J. C. McLaughlin is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (7 papers), Bacterial Identification and Susceptibility Testing (6 papers) and Escherichia coli research studies (6 papers). J. C. McLaughlin collaborates with scholars based in United States, Bangladesh and United Kingdom. J. C. McLaughlin's co-authors include Steven M. Smith, David R. Nalin, Jyotsnamoy Chakraborty, Atikur Rahman, B. A. Cunha, Richard Quintiliani, Frits Ørskov, I Orskóv, R. Bradley Sack and Mohammad Yunus and has published in prestigious journals such as The Lancet, The Journal of Chemical Physics and Clinical Infectious Diseases.

In The Last Decade

J. C. McLaughlin

26 papers receiving 510 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. C. McLaughlin United States 10 224 216 138 128 97 28 613
Lifen Hu China 17 293 1.3× 212 1.0× 288 2.1× 106 0.8× 72 0.7× 49 774
Andrea J. Linscott United States 10 91 0.4× 192 0.9× 61 0.4× 62 0.5× 111 1.1× 18 485
Ying Ye China 13 226 1.0× 97 0.4× 287 2.1× 91 0.7× 40 0.4× 35 576
J. Papavassiliou Greece 13 73 0.3× 130 0.6× 147 1.1× 102 0.8× 105 1.1× 89 602
Alex C. Sonnenwirth United States 16 118 0.5× 125 0.6× 53 0.4× 124 1.0× 51 0.5× 32 576
Paulo Afonso Nogueira Brazil 17 120 0.5× 206 1.0× 47 0.3× 79 0.6× 68 0.7× 55 1.2k
Lucio Romano Italy 16 128 0.6× 322 1.5× 106 0.8× 239 1.9× 134 1.4× 26 754
Paraskevi Chra Greece 7 56 0.3× 221 1.0× 83 0.6× 37 0.3× 38 0.4× 11 425
Laurence R. McCarthy United States 14 83 0.4× 147 0.7× 68 0.5× 220 1.7× 39 0.4× 37 599
Cristina Belmar Campos Germany 11 140 0.6× 103 0.5× 285 2.1× 57 0.4× 71 0.7× 20 505

Countries citing papers authored by J. C. McLaughlin

Since Specialization
Citations

This map shows the geographic impact of J. C. McLaughlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. C. McLaughlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. C. McLaughlin more than expected).

Fields of papers citing papers by J. C. McLaughlin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. C. McLaughlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. C. McLaughlin. The network helps show where J. C. McLaughlin may publish in the future.

Co-authorship network of co-authors of J. C. McLaughlin

This figure shows the co-authorship network connecting the top 25 collaborators of J. C. McLaughlin. A scholar is included among the top collaborators of J. C. McLaughlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. C. McLaughlin. J. C. McLaughlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McLaughlin, J. C., Catherine A. Panozzo, Eileen Schneider, et al.. (2010). Outbreak of adenovirus 14 respiratory illness - Prince of Wales Island, Alaska, 2008.. MMWR Morbidity and Mortality Weekly Report. 59(1). 6–10. 20 indexed citations
2.
Barry, A L, Peter Fuchs, C Thornsberry, et al.. (1996). Methods of measuring susceptibility of anaerobic bacteria to trovafloxacin, including quality control parameters. European Journal of Clinical Microbiology & Infectious Diseases. 15(8). 676–678. 3 indexed citations
3.
Breiman, Robert F., Thomas G. Ksiazek, Pierre E. Rollin, et al.. (1996). Evidence Against Person-to-Person Transmission of Hantavirus to Health Care Workers. Clinical Infectious Diseases. 22(5). 824–826. 53 indexed citations
4.
Arıkan, S., R Auckenthaler, Tom Bergan, et al.. (1996). Susceptibility testing of Haemophilus influenzae— an international collaborative study in quality assessment. Journal of Antimicrobial Chemotherapy. 38(3). 363–386. 8 indexed citations
5.
Sewell, D L, A L Barry, S D Allen, et al.. (1995). Comparative antimicrobial activities of the penem WY-49605 (SUN5555) against recent clinical isolates from five U.S. medical centers. Antimicrobial Agents and Chemotherapy. 39(7). 1591–1595. 4 indexed citations
6.
McLaughlin, J. C. & Steven M. Smith. (1994). Metabolic regulation of glyoxylate-cycle enzyme synthesis in detached cucumber cotyledons and protoplasts. Planta. 195(1). 45 indexed citations
7.
Barry, A L, Peter Fuchs, Fred C. Tenover, et al.. (1994). Interpretive criteria and quality control for antimicrobial susceptibility tests of levofloxacin. European Journal of Clinical Microbiology & Infectious Diseases. 13(10). 822–826. 7 indexed citations
8.
McLaughlin, J. C., A L Barry, Peter Fuchs, et al.. (1994). In-vitro activity of five β-lactam/β-lactamase inhibitor combinations against consecutive isolates of the Enterobacteriaceae and Pseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy. 33(2). 223–230. 9 indexed citations
9.
Foucar, Kathryn, Kurt B. Nolte, Richard M. Feddersen, et al.. (1994). Outbreak of Hantavirus pulmonary syndrome in the southwestern United States. Response of pathologists and other laboratorians.. PubMed. 101(4 Suppl 1). S1–5. 8 indexed citations
10.
Pfaller, Michael A., A L Barry, Peter Fuchs, et al.. (1993). Relative efficacy of tazobactam, sulbactam and clavulanic acid in enhancing the potency of ampicillin against clinical isolates ofEnterobacteriaceae. European Journal of Clinical Microbiology & Infectious Diseases. 12(3). 200–205. 5 indexed citations
11.
Pfaller, Michael A., A L Barry, L. D. Sabath, et al.. (1993). In vitro activity of ceftriaxone and other cephalosporins against 602 clinical isolates of staphylococci from geographically diverse medical centers. European Journal of Epidemiology. 9(6). 658–62. 4 indexed citations
12.
Pfaller, Michael A., A L Barry, Peter Fuchs, et al.. (1993). Comparison of fixed concentration and fixed ratio options for dilution susceptibility testing of gram-negative bacilli to ampicillin and ampicillin/sulbactam. European Journal of Clinical Microbiology & Infectious Diseases. 12(5). 356–362. 9 indexed citations
13.
Barry, A L, Peter Fuchs, J H Jorgensen, et al.. (1993). Susceptibility of Haemophilus influenzae to piperacillin-tazobactam combinations: interpretive criteria and quality control limits for standardized tests. Journal of Clinical Microbiology. 31(3). 751–753. 3 indexed citations
14.
Pfaller, Michael A., A L Barry, Peter Fuchs, et al.. (1992). Comparison of fixed concentration and fixed ratio options for testing susceptibility of gram-negative bacilli to piperacillin and piperacillin/tazobactam. European Journal of Clinical Microbiology & Infectious Diseases. 11(8). 728–732. 6 indexed citations
15.
Hardy, Dwight J., A L Barry, Peter Fuchs, et al.. (1992). Error rates in cefoperazone and cefoperazone-sulbactam disk tests withenterobacteriaceae andPseudomonas aeruginosa. European Journal of Clinical Microbiology & Infectious Diseases. 11(10). 926–930. 2 indexed citations
16.
Eisenfeld, Leonard, Herbert Silver, J. C. McLaughlin, et al.. (1992). Prevention of transfusion‐associated cytomegalovirus infection in neonatal patients by the removal of white cells from blood. Transfusion. 32(3). 205–209. 98 indexed citations
17.
Barry, A L, J H Jorgensen, Dwight J. Hardy, et al.. (1992). Interpretive criteria and quality control parameters for testing susceptibility of Haemophilus influenzae to enoxacin, ofloxacin, and temafloxacin. Journal of Clinical Microbiology. 30(11). 3013–3015. 4 indexed citations
18.
Nalin, David R. & J. C. McLaughlin. (1978). Effects of choleragenoid and glucose on the response of dog intestine to Escherichia coli enterotoxins. Journal of Medical Microbiology. 11(2). 177–186. 17 indexed citations
19.
Nalin, David R., Margubur Rahaman, J. C. McLaughlin, Mohammad Yunus, & George T. Curlin. (1975). ENTEROTOXIGENIC ESCHERICHIA COLI AND IDIOPATHIC DIARRHŒA IN BANGLADESH. The Lancet. 306(7945). 1116–1119. 47 indexed citations
20.
McLaughlin, J. C., et al.. (1952). Experimental Efforts to Find Radioactivity Induced by the Firing of Shaped Charges. The Journal of Chemical Physics. 20(6). 1049–1049. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026